Health News
- Conway Funnels $1.5 Million In Drug-company Settlements To Develop Prevention And Treatment Plan For Kids' Substance Abuse
With two lawsuit settlements from drug makers, Attorney General Jack Conway is giving the University of Kentucky $1.5 million over two years to develop a comprehensive plan for the prevention and treatment of substance abuse by adolescents. ?Adolescent...
- Pike County Settles Its Part Of Oxycontin Lawsuit Against Purdue Pharma For $4 Million; State Remains A Plaintiff
Officials of Pike County, Kentucky, announced this week that Purdue Pharma, the maker of OxyContin, will pay $4 million to settle the county's part of a lawsuit the county and state filed in 2007 seeking damages for the addiction OxyContin caused...
- Conway, Other Ags Ask Fda To Require Generic Prescription Pain Pills To Be Abuse-resistant, Tamper-resistant
Generic versions of popular pain relievers must be made harder to abuse, in order to curb prescription drug abuse that is epidemic in many states, Attorney General Jack Conway and 47 other attorneys general said in a letter sent to federal officials Monday....
- Pike Court Will Keep Lawsuit County And Attorney General Filed Against Purdue Pharma Over Damage Done By Its Oxycontin
A state court will hear the Kentucky attorney general's 2007 lawsuit against OxyContin manufacturer Purdue Pharma, against the wishes of the company. The U.S. Court of Appeals for the 2nd Circuit affirmed a lower court's order returning the...
- Conway Pushes For All States To Track Prescription Drugs
As Kentucky lawmakers consider legislation that would tackle suspect pain management clinics, the issue is making waves in Washington as well. On Thursday, Attorney General Jack Conway, right, told the U.S. Congress "that every state in the nation needs...
Health News
Kentucky gets $1.75 million in national settlement with big drug maker; marketing and promotional practices reined in
Kentucky will receive approximately $1.75 million from a $105 million national settlement with GlaxoSmithKline to resolve allegations that the pharmaceutical manufacturer unlawfully promoted its asthma drug, Advair, and its antidepressant drugs, Paxil and Wellbutrin, according to a press release from Attorney General Jack Conway's office.
The complaint and consent judgment alleges that GSK violated state consumer-protection laws by misrepresenting the uses and qualities of these drugs. Conway said in the release that this settlement will change the way pharmaceutical sales teams are motivated and paid.
The consent judgement requires GSK to reform its marketing and promotional practices, stating the company shall not: make any false, misleading or deceptive claim about its products; make claims not approved by the U.S. Food and Drug Administration; present information or conclusions from inadequate clinical studies; provide samples to health care professionals if they know it is being prescribed for non-approved use; or provide information describing any off-label use of a GSK product, unless consistent with applicable Food and Drug Administration regulations.
They must also continue a program through March 2019 that decreases financial incentives for sales representatives who use deceptive marketing practices, says the release. In addition, scientifically trained personnel will be responsible for providing unbiased and non-promotional information to health care providers.
Kentucky joined 43 other states and the District of Columbia in reaching the national settlement with GSK.
The complaint and consent judgment alleges that GSK violated state consumer-protection laws by misrepresenting the uses and qualities of these drugs. Conway said in the release that this settlement will change the way pharmaceutical sales teams are motivated and paid.
The consent judgement requires GSK to reform its marketing and promotional practices, stating the company shall not: make any false, misleading or deceptive claim about its products; make claims not approved by the U.S. Food and Drug Administration; present information or conclusions from inadequate clinical studies; provide samples to health care professionals if they know it is being prescribed for non-approved use; or provide information describing any off-label use of a GSK product, unless consistent with applicable Food and Drug Administration regulations.
They must also continue a program through March 2019 that decreases financial incentives for sales representatives who use deceptive marketing practices, says the release. In addition, scientifically trained personnel will be responsible for providing unbiased and non-promotional information to health care providers.
Kentucky joined 43 other states and the District of Columbia in reaching the national settlement with GSK.
- Conway Funnels $1.5 Million In Drug-company Settlements To Develop Prevention And Treatment Plan For Kids' Substance Abuse
With two lawsuit settlements from drug makers, Attorney General Jack Conway is giving the University of Kentucky $1.5 million over two years to develop a comprehensive plan for the prevention and treatment of substance abuse by adolescents. ?Adolescent...
- Pike County Settles Its Part Of Oxycontin Lawsuit Against Purdue Pharma For $4 Million; State Remains A Plaintiff
Officials of Pike County, Kentucky, announced this week that Purdue Pharma, the maker of OxyContin, will pay $4 million to settle the county's part of a lawsuit the county and state filed in 2007 seeking damages for the addiction OxyContin caused...
- Conway, Other Ags Ask Fda To Require Generic Prescription Pain Pills To Be Abuse-resistant, Tamper-resistant
Generic versions of popular pain relievers must be made harder to abuse, in order to curb prescription drug abuse that is epidemic in many states, Attorney General Jack Conway and 47 other attorneys general said in a letter sent to federal officials Monday....
- Pike Court Will Keep Lawsuit County And Attorney General Filed Against Purdue Pharma Over Damage Done By Its Oxycontin
A state court will hear the Kentucky attorney general's 2007 lawsuit against OxyContin manufacturer Purdue Pharma, against the wishes of the company. The U.S. Court of Appeals for the 2nd Circuit affirmed a lower court's order returning the...
- Conway Pushes For All States To Track Prescription Drugs
As Kentucky lawmakers consider legislation that would tackle suspect pain management clinics, the issue is making waves in Washington as well. On Thursday, Attorney General Jack Conway, right, told the U.S. Congress "that every state in the nation needs...